Fundraising FoxSpinnaker Biosciences
Solana Beach, US · Delaware corporation
Find your way into Spinnaker Biosciences
Sign up to see every warm intro you have to Spinnaker Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Spinnaker Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Spinnaker Biosciences develops porous silicon, porous silicon oxide, and silicon/polymer composite materials engineered as controlled-release drug delivery vehicles. Its biocompatible, biodegradable particles provide protected storage and sustained release of therapeutic payloads, with surface chemistry that supports targeting agents such as peptides and antibodies.
Founders & leadership
Board
WF
William FreemanBoard director
Reported raises · per SEC filings
Form D private placements$1.6M disclosed across 2 rounds · 2014–2024
▶$666.8KraisedDec 2024 · 1 investors · Other Health CareRule 506(b)
▶$666.8KraisedDec 2024 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Malcolm FinlaysonExecutive Officer, Director
- Michael SailorDirector
- William FreemanDirector
- Offering amount
- $1.3M
- Amount sold
- $666.8K
- First sale
- Nov 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$900KraisedMay 2015 · 2 investors · Other Health CareRule 506(b)
▶$900KraisedMay 2015 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Virgil ThompsonExecutive Officer, Director
- Michael SailorDirector
- William FreemanDirector
- Offering amount
- $3M
- Amount sold
- $900K
- First sale
- Oct 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Spinnaker Biosciences do?
- Spinnaker Biosciences develops porous silicon, porous silicon oxide, and silicon/polymer composite materials engineered as controlled-release drug delivery vehicles. Its biocompatible, biodegradable particles provide protected storage and sustained release of therapeutic payloads, with surface chemistry that supports targeting agents such as peptides and antibodies.
- How much funding has Spinnaker Biosciences raised?
- Spinnaker Biosciences has disclosed $1.6M raised across 2 rounds.
- Where is Spinnaker Biosciences headquartered?
- Spinnaker Biosciences is headquartered in Solana Beach, US.